Daiwa Securities Group Inc. Sells 674 Shares of National Health Investors, Inc. (NYSE:NHI)

Daiwa Securities Group Inc. lowered its holdings in National Health Investors, Inc. (NYSE:NHI) by 4.9% in the fourth quarter, HoldingsChannel.com reports. The firm owned 13,134 shares of the real estate investment trust’s stock after selling 674 shares during the quarter. Daiwa Securities Group Inc.’s holdings in National Health Investors were worth $734,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also recently made changes to their positions in the business. Baystate Wealth Management LLC acquired a new stake in shares of National Health Investors in the fourth quarter valued at approximately $39,000. Sound Income Strategies LLC increased its stake in National Health Investors by 33.5% during the 4th quarter. Sound Income Strategies LLC now owns 916 shares of the real estate investment trust’s stock worth $51,000 after acquiring an additional 230 shares during the period. EMC Capital Management raised its holdings in National Health Investors by 86.5% in the 3rd quarter. EMC Capital Management now owns 3,357 shares of the real estate investment trust’s stock valued at $172,000 after acquiring an additional 1,557 shares in the last quarter. AlphaMark Advisors LLC bought a new stake in shares of National Health Investors during the 3rd quarter valued at $249,000. Finally, Van ECK Associates Corp grew its holdings in shares of National Health Investors by 4.3% during the 3rd quarter. Van ECK Associates Corp now owns 4,889 shares of the real estate investment trust’s stock worth $251,000 after purchasing an additional 202 shares in the last quarter. Institutional investors and hedge funds own 62.51% of the company’s stock.

National Health Investors Trading Down 0.4 %

Shares of NYSE NHI opened at $62.61 on Friday. The firm has a 50 day moving average price of $59.56 and a two-hundred day moving average price of $55.61. The stock has a market cap of $2.72 billion, a P/E ratio of 20.00 and a beta of 0.95. National Health Investors, Inc. has a 52-week low of $47.54 and a 52-week high of $63.19. The company has a debt-to-equity ratio of 0.90, a quick ratio of 10.27 and a current ratio of 10.27.

National Health Investors Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 3rd. Investors of record on Thursday, March 28th will be issued a $0.90 dividend. The ex-dividend date is Wednesday, March 27th. This represents a $3.60 dividend on an annualized basis and a yield of 5.75%. National Health Investors’s payout ratio is 115.02%.

Insiders Place Their Bets

In related news, Director Charlotte A. Swafford purchased 10,000 shares of the firm’s stock in a transaction dated Tuesday, February 27th. The stock was bought at an average price of $58.69 per share, with a total value of $586,900.00. Following the completion of the purchase, the director now owns 110,185 shares in the company, valued at approximately $6,466,757.65. The acquisition was disclosed in a filing with the SEC, which is accessible through this hyperlink. Company insiders own 7.26% of the company’s stock.

Analyst Ratings Changes

NHI has been the subject of a number of analyst reports. Wells Fargo & Company raised National Health Investors from an “equal weight” rating to an “overweight” rating and boosted their price target for the company from $55.00 to $63.00 in a research note on Monday, February 26th. StockNews.com lowered shares of National Health Investors from a “buy” rating to a “hold” rating in a research report on Thursday, April 18th. Truist Financial boosted their price objective on shares of National Health Investors from $55.00 to $58.00 and gave the company a “hold” rating in a research report on Thursday, April 4th. Wedbush raised their target price on National Health Investors from $64.00 to $66.00 and gave the company an “outperform” rating in a report on Monday, March 18th. Finally, BMO Capital Markets raised National Health Investors from a “market perform” rating to an “outperform” rating and set a $67.00 price target for the company in a report on Tuesday, March 12th. Five research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $60.50.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.